Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overnight sleep features and next-morning brain metabolism in older adults.

Sleep medicine·2026
Same author

Three-dimensional direct neuronal reprogramming for modeling Alzheimer's disease neuropathology.

Nature protocols·2026
Same author

Planimetric and Linear MRI Markers for Progressive Supranuclear Palsy Classification: A Large Multicohort International Study.

Radiology·2026
Same author

Greater hypoxic burden predicts weaker coordination between brain pulsation and CSF flow on 7T MRI independent of non-hypoxic arousals: Implications for glymphatic activity.

bioRxiv : the preprint server for biology·2026
Same author

"Hypoxic burden" is a concept, not a single variable.

Sleep·2026
Same author

Factors influencing accelerated progression in behavioral variant frontotemporal dementia.

Journal of neurology·2026

Related Experiment Video

Updated: Jun 23, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Emerging directions in tauopathy research.

Luc Buée1, Kristin R Wildsmith2, Suvarna Alladi3

  • 1Lille Neuroscience and Cognition, Univ. Lille, Inserm, CHU-Lille, Lille, France.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|June 21, 2026
PubMed
Summary

International experts convened at the Tau Global Conference 2025 to discuss tauopathy research. Advances in tau biology, biomarkers, and therapeutics were highlighted, emphasizing global collaboration for clinical applications.

Keywords:
biomarkersneurodegenerationprecision medicinetauopathiestherapeutics

More Related Videos

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons
05:51

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

Published on: May 23, 2019

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

Related Experiment Videos

Last Updated: Jun 23, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons
05:51

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

Published on: May 23, 2019

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

Area of Science:

  • Neuroscience
  • Biomedical Research
  • Clinical Medicine

Background:

  • Tauopathies, including Alzheimer's disease, are a significant public health concern.
  • Understanding tau biology is crucial for developing effective treatments.
  • Current research faces challenges in diagnosis, staging, and therapeutic development.

Purpose of the Study:

  • To synthesize key insights from the Tau Global Conference 2025.
  • To highlight advances and challenges in tauopathy research.
  • To underscore the importance of interdisciplinary and global approaches.

Main Methods:

  • Convening international experts from academia, industry, government, and philanthropy.
  • Reviewing emerging models of tau regulation, degradation, and propagation.
  • Discussing advances in biomarker development and therapeutic strategies.

Main Results:

  • Progress in understanding tau biology, including regulation, degradation, and propagation.
  • Advances in developing biomarkers for diagnosis and staging of tauopathies.
  • Evolving therapeutic strategies targeting tau pathophysiology.

Conclusions:

  • Cross-sector collaboration and global initiatives are vital for tau research.
  • Interdisciplinary, biomarker-driven, and globally inclusive approaches accelerate clinical translation.
  • Continued research is critical for effective clinical applications in tauopathies.